LYTTON LAURENCE W 13D and 13G filings for Cidara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-15 1:09 pm Sale | 2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | LYTTON LAURENCE W | 85,416 2.500% | -81,604 (-48.86%) | Filing |
| 2021-03-05 7:26 pm Purchase | 2021-02-25 | 13G | Cidara Therapeutics, Inc. CDTX | LYTTON LAURENCE W | 167,020 7.000% | 30,666 (+22.49%) | Filing |
| 2021-03-05 4:55 pm Purchase | 2021-02-25 | 13G | Cidara Therapeutics, Inc. CDTX | LYTTON LAURENCE W | 136,354 5.700% | 136,354 (New Position) | Filing |